样式: 排序: IF: - GO 导出 标记为已读
-
Response to Philips et al.: Several Fundamental Misconceptions about Evidence-Based Practice. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-09-05 Sophie Juul,Janus Christian Jakobsen,Emilie Hestbaek,Caroline Barkholt Kamp,Markus Harboe Olsen,Marie Rishede,Frederik Weischer Frandsen,Sune Bo,Stig Poulsen,Per Sørensen,Anthony Bateman,Sebastian Simonsen
-
Nocebo and Placebo Effects and Their Implications in Psychotherapy. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-08-30 Winfried Rief,Marcel Wilhelm
-
Reducing Distress from Auditory Verbal Hallucinations: A Multicenter, Parallel, Single-Blind, Randomized Controlled Feasibility Trial of Relating Therapy. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-08-21 Tania Marie Lincoln,Björn Schlier,Rebecca Müller,Mark Hayward,Anne-Katharina Fladung,Niklas Bergmann,Kerem Böge,Jürgen Gallinat,Candelaria Mahlke,Uwe Gonther,Thomas Lang,Cornelia Exner,Anika Buchholz,Katharina Stahlmann,Antonia Zapf,Geraldine Rauch,Matthias Pillny
INTRODUCTION There is a significant demand for interventions that reduce distress related to auditory verbal hallucinations (AVHs). AVH distress is associated with the way voice hearers relate with AVHs. We aimed to establish the feasibility of a randomized controlled trial to demonstrate that adding "Relating Therapy" (RT) to treatment as usual (TAU) is superior to TAU in reducing AVH distress. METHODS
-
Flaws in the Design of a Randomized Controlled Trial Comparing Short-Term versus Long-Term Mentalization-Based Therapy for Borderline Personality Disorder. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-31 Björn Philips,Falk Leichsenring,Henning Jordet,Sigmund Karterud
-
Adverse Events of Psychological Interventions: Definitions, Assessment, Current State of the Research and Implications for Research and Clinical Practice. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-29 Jan Philipp Klein,Alexander Rozental,Svenja Sürig,Steffen Moritz
BACKGROUND The effectiveness of psychological interventions is undisputed. But while in other fields of health care the safety of interventions is studied alongside effectiveness, adverse events (AEs) have only recently been assessed in clinical studies of psychological interventions. This critical review summarizes the definition, assessment and current research status of AEs of psychological interventions
-
Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-23 Fiammetta Cosci,Virginie-Anne Chouinard,Guy Chouinard
INTRODUCTION Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) may cause withdrawal at dose decrease, discontinuation, or switch. Current diagnostic methods (e.g., DSM) do not take such phenomenon into account. Using a new nosographic classification of withdrawal syndromes due to SSRI/SNRI decrease or discontinuation [by Psychother Psychosom. 2015;84(2):63-71]
-
The Clinical Meaning of Withdrawal with Antidepressant Drugs. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-18 Giovanni A Fava
-
The Effectiveness of Dialectical Behavior Therapy Compared to Schema Therapy for Borderline Personality Disorder: A Randomized Clinical Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-10 Nele Assmann,Anja Schaich,Arnoud Arntz,Till Wagner,Philipp Herzog,Daniel Alvarez-Fischer,Valerija Sipos,Kamila Jauch-Chara,Jan Philipp Klein,Michael Hüppe,Ulrich Schweiger,Eva Fassbinder
INTRODUCTION In the treatment of borderline personality disorder (BPD), there is empirical support for both dialectical behavior therapy (DBT) and schema therapy (ST); these treatments have never been compared directly. This study examines whether either of them is more effective than the other in treating patients with BPD. METHODS In this randomized, parallel-group, rater-blind clinical trial, outpatients
-
Emotional Changes during Imagery Rescripting of Aversive Social Memories in Social Anxiety Disorder: A Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-26 Rosa J Seinsche,Susanne Fricke,Marie K Neudert,Raphaela I Zimmer,Rudolf Stark,Andrea Hermann
INTRODUCTION Imagery rescripting (ImRs) is a psychotherapeutic intervention targeting aversive memories. During the three-phase intervention, patients reexperience their aversive memory (phase 1), observe the scene from their adult perspective, and intervene to help their former selves (phase 2), and reexperience it again with the positive changes (phase 3). Previous studies have rarely investigated
-
Prevalence and Rapid Screen Method of Diagnostic Criteria for Psychosomatic Research Syndromes in Human Papillomavirus-Infected Patients. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-26 Xuelian Cui,Lixin Ding,Yongjuan Xu,Xiaosong Yuan,Qiaoli Zhang,Chiara Rafanelli,Sara Gostoli,Zhiwei Liu,Jianxin Cao
INTRODUCTION The early and rapid identification of psychosomatic symptoms is crucial to prevent harmful outcomes in patients with human papillomavirus (HPV) infection in busy comprehensive clinics. This study aimed to explore the prevalence and rapid screening method of the Diagnostic Criteria for Psychosomatic Research-revised (DCPR) syndromes in patients with HPV infection. METHODS A total of 504
-
The Future of Enhanced Psychotherapy: Towards Precision Psychotherapy. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-26 Stephan Zipfel,Wolfgang Lutz,Silvia Schneider,Elisabeth Schramm,Jaime Delgadillo,Katrin E Giel
-
Randomization Bias, Multi-Morbidity, and the Composite Clinical Score. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-18 Ralph I Horwitz,James B Baker,Arnab Ghatak,Mark R Cullen
-
The Role of Neurosciences in Clinical Interviewing. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-14 Stefano Pallanti
-
Appreciating the Limits and Opportunities of Meta-Analyses to Understand Complex Psychological Trajectories: Reply to da Silveira et al. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-05 Amelia J Scott,Ashleigh B Correa,Madelyne A Bisby,Blake F Dear
-
Treating Posttraumatic Stress Disorder: The Complexities of the Clinical Realm. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-05-20 Ulrich Schnyder
-
Enhanced Skills Training in Affective and Interpersonal Regulation versus Treatment as Usual for ICD-11 Complex PTSD: A Pilot Randomised Controlled Trial (The RESTORE Trial). Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-30 Thanos Karatzias,Mark Shevlin,Marylène Cloitre,Walter Busuttil,Katherine Graham,Laura Hendrikx,Philip Hyland,Natasha Biscoe,Dominic Murphy
INTRODUCTION Complex PTSD (CPTSD) is a relatively new condition in ICD-11. This pilot randomised controlled trial aimed to compare a four-module intervention developed to target all symptoms of ICD-11 CPTSD, namely Enhanced Skills in Affective and Interpersonal Regulation (ESTAIR) with treatment as usual (TAU). The purpose of the study was to assess feasibility, safety, acceptability, and preliminary
-
Efficacy of an Internet- and Mobile-Based Intervention for Subclinical Anxiety and Depression (ICare Prevent) with Two Guidance Formats: Results from a Three-Armed Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-30 Anna-Carlotta Zarski,Kiona K Weisel,Thomas Berger,Tobias Krieger,Michael P Schaub,Matthias Berking,Dennis Görlich,Corinna Jacobi,David D Ebert
INTRODUCTION Limited research exists on intervention efficacy for comorbid subclinical anxiety and depressive disorders, despite their common co-occurrence. Internet- and mobile-based interventions (IMIs) are promising to reach individuals facing subclinical symptoms. OBJECTIVE This study aimed to evaluate the efficacy of a transdiagnostic and self-tailored IMI in reducing subclinical anxiety and depressive
-
Clinical Use of Staging in Psychiatry. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-18 Giovanni A Fava
-
Long-Term Effectiveness of Cognitive Behavioral Therapy in Routine Outpatient Care for Youth with Anxiety Disorders. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-12 Karen Krause,Xiao Chi Zhang,Silvia Schneider
INTRODUCTION This study examined the long-term effectiveness of cognitive behavioral therapy (CBT) (≥ 2 years after the end of therapy) in the routine care of youth (mean 11.95 years; SD = 3.04 years) with primary anxiety disorder (AD). METHODS Two hundred and ten children with any AD as a primary diagnosis and with any comorbidity were included in the "Kids Beating Anxiety (KibA)" clinical trial and
-
The Endeavor to Predict Depression and Anxiety Trajectories in the Context of Chronic Diseases Remains a Formidable Challenge. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-12 Pedro Lucas Santana da Silveira,Guilherme Nobre Nogueira,Marisa Bezerra de Araújo,Fabio Gomes de Matos E Souza,Luísa Weber Bisol
-
Indicated Stress Prevention Addressing Adolescents with High Stress Levels Based on Principles of Acceptance and Commitment Therapy: A Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-08 Franziska Binder,Julian Koenig,Franz Resch,Michael Kaess
INTRODUCTION Stress affects many adolescents and is associated with physical and mental health symptoms that can have a negative impact on normative development. However, there are very few evidence-based, specific treatment approaches. The aim of the study was to investigate an eight-session group intervention using components of Acceptance and Commitment Therapy (ACT) enriched with elements of CBT
-
The Impact of Online Health Information Seeking on Patients, Clinicians, and Patient-Clinician Relationship. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-03-26 Vladan Starcevic
-
Restoring and Preserving the Clinical Interview. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-03-15 Kurt Kroenke
-
Will Interviewing Become a Lost Art? Psychother. Psychosom. (IF 16.3) Pub Date : 2024-03-08 Steven L Dubovsky
-
Acceptance and Commitment Therapy, Combined with Bedtime Restriction, versus Cognitive Behavioral Therapy for Insomnia: A Randomized Controlled Pilot Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-02-28 Elisabeth Hertenstein,Ersilia Trinca,Carlotta L Schneider,Kristoffer D Fehér,Anna F Johann,Christoph Nissen
INTRODUCTION Cognitive behavioral therapy for insomnia (CBT-I) is the current first-line treatment for insomnia. However, rates of nonresponse and nonremission are high and effects on quality of life are only small to moderate, indicating a need for novel treatment developments. We propose that Acceptance and Commitment Therapy (ACT) addresses core pathophysiological pathways of insomnia. ACT therefore
-
Clinical Interviewing: An Essential but Neglected Method of Medicine. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-02-21 Giovanni A Fava,Nicoletta Sonino,David C Aron,Richard Balon,Carmen Berrocal Montiel,Jianxin Cao,John Concato,Ajandek Eory,Ralph I Horwitz,Chiara Rafanelli,Ulrich Schnyder,Hongxing Wang,Thomas N Wise,Jesse H Wright,Stephan Zipfel,Chiara Patierno
Clinical interviewing is the basic method to understand how a person feels and what are the presenting complaints, obtain medical history, evaluate personal attitudes and behavior related to health and disease, give the patient information about diagnosis, prognosis, and treatment, and establish a bond between patient and physician that is crucial for shared decision making and self-management. However
-
Psychological Treatment of Comorbid Insomnia and Depression: A Double-Blind Randomized Placebo-Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-01-29 Kerstin Blom,Erik Forsell,Monica Hellberg,Cecilia Svanborg,Susanna Jernelöv,Viktor Kaldo
INTRODUCTION Insomnia and depression are highly prevalent disorders and commonly occur together. Cognitive behavioral therapy for insomnia, CBT-I, has been shown to be effective in treating insomnia and also comorbid depression. However, it is unclear whether effects of CBT-I on depression are specific or nonspecific. Also, depressive symptoms often remain too high after CBT-I, indicating a need for
-
Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-01-25 Taeho Greg Rhee,Sung Ryul Shim,Kevin J Manning,Howard A Tennen,Tyler S Kaster,Giacomo d'Andrea,Brent P Forester,Andrew A Nierenberg,Roger S McIntyre,David C Steffens
INTRODUCTION Cognitive dysfunction or deficits are common in patients with major depressive disorder (MDD). The current study systematically reviews and meta-analyzes multiple domains of cognitive impairment in patients with MDD. METHODS PubMed/MEDLINE, PsycINFO, Cochrane Library, Embase, Web of Science, and Google Scholar were searched from inception through May 17, 2023, with no language limits.
-
One-Day Peer-Delivered Cognitive Behavioral Therapy-Based Workshops for Postpartum Depression: A Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-01-25 Zoryana Babiy,Haley Layton,Calan D Savoy,Feng Xie,June S L Brown,Peter J Bieling,David L Streiner,Mark A Ferro,Ryan J Van Lieshout
INTRODUCTION Myriad treatment barriers prevent birthing parents with postpartum depression (PPD) from receiving timely treatment. We aimed to determine whether a peer-delivered online 1-day cognitive behavioral therapy (CBT)-based workshop added to treatment as usual (TAU) improves PPD and its comorbidities and is more cost-effective than TAU alone. METHODS This parallel-group, randomized controlled
-
Mortality and Lithium-Protective Effects after First-Episode Mania Diagnosis in Bipolar Disorder: A Nationwide Retrospective Cohort Study in Taiwan. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-01-09 Andre F Carvalho,Chih-Wei Hsu,Eduard Vieta,Marco Solmi,Wolfgang Marx,Michael Berk,Chih-Sung Liang,Ping-Tao Tseng,Liang-Jen Wang
INTRODUCTION This study aimed to estimate all-cause mortality in patients after a first-episode mania (FEM) and examine whether six guideline-recommended medications can reduce mortality. METHODS The cohort included population-based FEM samples and matched controls from Taiwan, spanning 2007 to 2018. The primary outcomes assessed were all-cause/suicide-related mortality, while the secondary outcome
-
Rasch Analysis and Its Relevance to Psychosomatic Medicine. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-01-04 Kaj Sparle Christensen,Fiammetta Cosci,Danilo Carrozzino,Tom Sensky
-
Effectiveness of Schema Therapy versus Cognitive Behavioral Therapy versus Supportive Therapy for Depression in Inpatient and Day Clinic Settings: A Randomized Clinical Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-01-04 Johannes Kopf-Beck,Celina L Müller,Jeanette Tamm,Julia Fietz,Nils Rek,Leah Just,Zoe Ilona Spock,Katharina Weweck,Keisuke Takano,Martin Rein,Martin E Keck,Samy Egli
INTRODUCTION Schema therapy (ST) reduces depressive symptoms, but clinical trials have not investigated its effectiveness for patients suffering from severe forms of depression and high rates of comorbidities. There is high demand for exploring and improving treatments for this patient group. The objective of the current study was to evaluate whether ST is more effective than individual supportive
-
Longitudinal Clusters of Long-Term Trajectories in Patients with Early-Onset Chronic Depression: 2 Years of Naturalistic Follow-Up after Extensive Psychological Treatment. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-12-28 Moritz Elsaesser,Bernd Feige,Levente Kriston,Lea Schumacher,Jasmin Peifer,Martin Hautzinger,Martin Härter,Elisabeth Schramm
INTRODUCTION In clinical trials, mostly group-level treatment effects of repeated cross-sectional measures are analyzed. However, substantial heterogeneity regarding individual symptom profiles and the variability of treatment effects are often neglected, especially over the long-term course. To provide effective personalized treatments, investigations of these characteristics are urgently needed.
-
Exploring the Relationship between Adherence to Therapy, Treatment Acceptability, and Clinical Outcomes in Adults with Attention-Deficit/Hyperactivity Disorder: Results from the COMPAS Multicenter Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-12-22 Carlos López-Pinar,Helena Rosen,Benjamin Selaskowski,Christian Staerk,Thomas Jans,Wolfgang Retz,Petra Retz-Junginger,Michael Roesler,Esther Sobanski,Michael Huss,Swantje Matthies,Ludger Tebartz van Elst,Mathias Berger,Christian Jacob,Bernhard Kis,Michael Colla,Barbara Alm,Mona Abdel-Hamid,Sonia Martínez-Sanchís,Enrique Carbonell-Vayá,Silke Lux,Alexandra Philipsen
INTRODUCTION Cognitive behavioral therapy and dialectical behavior therapy (DBT) can be effective in treating adults with ADHD, and patients generally consider these interventions useful. While adherence, as measured by attendance at sessions, is mostly sufficient, adherence to therapy skills has not been assessed. Furthermore, the relationship between patient evaluation of therapy effectiveness, treatment
-
Screening Second Victims for Emotional Distress: Assessment of the Clinimetric Properties of the WITHSTAND-PSY Questionnaire. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-12-20 Isolde Martina Busch,Maria Angela Mazzi,Loretta Berti,Albert W Wu,Fiammetta Cosci,Veronica Marinelli,Francesca Moretti,Michela Rimondini
INTRODUCTION Adverse events (AEs) are a leading cause of patient morbidity and mortality, greatly impacting healthcare providers' well-being (second victim (SV) phenomenon). Since it is not accurately captured by existing psychometric instruments, we developed a clinimetric instrument for assessing SVs' emotional distress before and after an AE. METHODS Content validity and clinical utility of the
-
The Extrapyramidal Symptom Rating Scale and Its Abbreviated Version: A Critical Review of Clinimetric Properties. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-12-07 Guy Chouinard,Fiammetta Cosci,Virginie-Anne Chouinard,Larry Alphs
BACKGROUND The Extrapyramidal Symptom Rating Scale - Abbreviated (ESRS-A) is an abbreviated version of the Extrapyramidal Symptom Rating Scale (ESRS) with instructions, definitions, and a semi-structured interview that follows clinimetric concepts of measuring clinical symptoms. Similar to the ESRS, the ESRS-A was developed to assess four types of drug-induced movement disorders (DIMD): parkinsonism
-
The Use of Authorized Concealment to Minimize Nocebo Side Effects: A Survey of US Public Attitudes. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-12-01 Andrew L Geers,Emily K Spotts,Michael Vang,Samantha R Mayer,Franklin G Miller
INTRODUCTION To minimize nocebo effects, it may be possible to employ authorized concealment, in which clinicians tell patients about the nocebo phenomenon and ask if they would prefer not to be informed about mild treatment side effects. OBJECTIVE The objective of the study was to understand public evaluations of authorized concealment for reducing nocebo effects. METHODS An online cross-sectional
-
The Effects of Mindfulness for Youth (MYmind) versus Group Cognitive Behavioral Therapy in Improving Attention and Reducing Behavioral Problems among Children with Attention-Deficit Hyperactivity Disorder and Their Parents: A Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-12-01 Samuel Yeung Shan Wong,Stanley Kam Chung Chan,Benjamin Hon Kei Yip,Wenyue Wang,Herman Hay Ming Lo,Dexing Zhang,Susan M Bögels
INTRODUCTION There is a lack of studies evaluating mindfulness-based interventions for children with attention-deficit hyperactivity disorder (ADHD) compared with an evidence-based control. This randomized controlled trial (RCT) evaluated the effects of mindfulness for youth (MYmind) in improving children's attention, behavior, and parent-related outcomes versus cognitive behavioral therapy (CBT).
-
Precision Medicine and the Challenges of Human Complexity. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-11-17 David C Aron
-
Effects of a Web-Based Behavioral Activation Intervention on Depressive Symptoms, Activation, Motivation, and Volition: Results of a Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-11-08 Claudia Mueller-Weinitschke,Jürgen Bengel,Harald Baumeister,Lena Violetta Krämer
INTRODUCTION Behavioral activation (BA) is effective for the treatment of depression. The Health Action Process Approach (HAPA), which is derived from health psychology, can provide a motivational-volitional framework of BA. OBJECTIVE This study investigated the efficacy of a HAPA-based internet-delivered BA intervention (iBA; called InterAKTIV) in individuals with depression, also assessing HAPA-based
-
Short-Term versus Long-Term Mentalization-Based Therapy for Borderline Personality Disorder: A Randomized Clinical Trial (MBT-RCT). Psychother. Psychosom. (IF 16.3) Pub Date : 2023-11-07 Sophie Juul,Janus Christian Jakobsen,Emilie Hestbaek,Caroline Kamp Jørgensen,Markus Harboe Olsen,Marie Rishede,Frederik Weischer Frandsen,Sune Bo,Susanne Lunn,Stig Poulsen,Per Sørensen,Anthony Bateman,Sebastian Simonsen
INTRODUCTION Borderline personality disorder (BPD) is a severe and prevalent psychiatric disorder. Mentalization-based therapy (MBT) is an evidence-based intervention for BPD, and several countries offer treatment programs for BPD lasting for years, which is resource demanding. No previous trial has compared short-term with long-term MBT. OBJECTIVE The aim of the study was to assess the efficacy and
-
Allostatic Load and Allostatic Overload: Preventive and Clinical Implications. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-11-06 Monique C Pfaltz,Ulrich Schnyder
-
Management of Depression in Medical Patients: The Role of Clinical Evaluation. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-10-20 Giovanni A Fava,Jenny Guidi
-
Symptom Change during Waitlist for Medicated and Nonmedicated Patients with Chronic Depression. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-09-14 Andreas Høstmælingen,Helene Amundsen Nissen-Lie,Bruce Wampold,Pål G Ulvenes
INTRODUCTION Patients seeking psychotherapy often spend time on waitlist (WL), the effect of which is largely unknown. WL patients may forego alternative non-psychotherapeutic assistance and thus do more poorly than had they not been placed on a WL. The course of symptoms might also be influenced by use of antidepressant medication (ADM), an issue that remains unexplored in the literature. OBJECTIVE
-
Illness Denial in Medical Conditions: The Time Has Come to Include It in DSM Iterations. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-09-05 Thomas N Wise
-
Allostatic Load in Children and Adolescents: A Systematic Review. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-09-04 Marcella Lucente,Jenny Guidi
INTRODUCTION The concept of allostatic load encompasses the cumulative effects of both ordinary daily life events as well as major challenges, and also includes related health-damaging behavior. Allostatic overload ensues when environmental challenges exceed the individual's ability to cope. Identification of allostatic load is carried out through the use of biomarkers and clinimetric criteria. Studies
-
Depression and Anxiety Trajectories in Chronic Disease: A Systematic Review and Meta-Analysis. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-08-22 Amelia J Scott,Ashleigh B Correa,Madelyne A Bisby,Blake F Dear
INTRODUCTION People living with chronic diseases are at an increased risk of anxiety and depression, which are associated with poorer medical and psychosocial outcomes. Many studies have examined the trajectories of depression and anxiety in people with specific diseases, including the predictors of these trajectories. This is valuable for understanding the process of adjustment to diseases and informing
-
The Ghent Psychotherapy Study: A Pragmatic, Stratified, Randomized Parallel Trial into the Differential Efficacy of Psychodynamic and Cognitive-Behavioral Interventions in Dependent and Self-Critical Depressive Patients. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-08-10 Reitske Meganck,Mattias Desmet,Kimberly Van Nieuwenhove,Melissa De Smet,Vicky Hennissen,Femke Truijens,Rosa De Geest,Goedele Hermans,Claudi Bockting,Ufuoma Angelica Norman,Tom Loeys,Ruth Inslegers,Tim Van den Abeele,Chris Baeken,Stijn Vanheule
INTRODUCTION Different types of psychotherapy are effective for treating major depressive disorder across groups yet show large within-group differences. Patient personality style is considered a potentially useful variable for treatment matching. OBJECTIVE This study is the first experimental test of the interaction between therapeutic approach and patients' dependent versus self-critical personality
-
Brief Psychotherapeutic Intervention Compared with Treatment as Usual for Adolescents with Nonsuicidal Self-Injury: Outcomes over a 2-4-Year Follow-Up. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-07-24 Franziska Rockstroh,Alexandra Edinger,Johannes Josi,Gloria Fischer-Waldschmidt,Romuald Brunner,Franz Resch,Michael Kaess
INTRODUCTION The "Cutting Down Programme" (CDP), a brief psychotherapeutic intervention for treating nonsuicidal self-injury (NSSI) in adolescents, was comparable to high-quality treatment as usual (TAU) in a previous randomized controlled trial (RCT). OBJECTIVE The aim of the study was to evaluate the long-term outcomes of the CDP over up to 4 years. METHODS Assessments of NSSI, suicide attempts,
-
Illness Denial in Medical Disorders: A Systematic Review. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-07-10 Chiara Patierno,Giovanni A Fava,Danilo Carrozzino
INTRODUCTION Illness denial pertains to medical patients who do not acknowledge the presence or severity of their disease or the need of treatment. OBJECTIVE This systematic review was performed to clarify the clinical role and manifestations of illness denial, its impact on health attitudes and behavior, as well as on short- and long-term outcomes in patients with medical disorders. METHODS The systematic
-
Behavioural Activation versus Treatment as Usual for Depressed Older Adults in Primary Care: A Pragmatic Cluster-Randomised Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-06-29 Noortje P Janssen,Peter Lucassen,Marcus J H Huibers,David Ekers,Theo Broekman,Judith E Bosmans,Harm Van Marwijk,Jan Spijker,Richard Oude Voshaar,Gert-Jan Hendriks
INTRODUCTION Effective non-pharmacological treatment options for depression in older adults are lacking. OBJECTIVE The effectiveness of behavioural activation (BA) by mental health nurses (MHNs) for depressed older adults in primary care compared with treatment as usual (TAU) was evaluated. METHODS In this multicentre cluster-randomised controlled trial, 59 primary care centres (PCCs) were randomised
-
Virtual Reality Exposure to a Healthy Weight Body Is a Promising Adjunct Treatment for Anorexia Nervosa. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-05-30 Simone C Behrens,Joachim Tesch,Philine J B Sun,Sebastian Starke,Michael J Black,Hannah Schneider,Jacopo Pruccoli,Stephan Zipfel,Katrin E Giel
INTRODUCTION/OBJECTIVE Treatment results of anorexia nervosa (AN) are modest, with fear of weight gain being a strong predictor of treatment outcome and relapse. Here, we present a virtual reality (VR) setup for exposure to healthy weight and evaluate its potential as an adjunct treatment for AN. METHODS In two studies, we investigate VR experience and clinical effects of VR exposure to higher weight
-
The World Federation for Psychotherapy (WFP) 23rd World Congress of Psychotherapy. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-05-25
-
The Importance of Symptom Reduction for Functional Improvement after Cognitive Behavioral Therapy for Anxiety and Depression: A Causal Mediation Analysis. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-05-24 Otto R F Smith,Leif E Aarø,Marit Knapstad
INTRODUCTION The temporal relationship between symptoms and functioning in the context of cognitive behavioral therapy (CBT) for anxiety and depression is not fully understood, and there are few high-quality studies that have examined to what extent late intervention effects of CBT on functioning are mediated by initial intervention effects on symptoms while accounting for the initial effects on functioning
-
Discontinuation of Antidepressant Medications: A Significant Healthcare Problem Insufficiently Addressed by the NICE Guidelines. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-05-24 Fiammetta Cosci,Virginie-Anne Chouinard,Guy Chouinard
-
Psychotherapy for Chronic In- and Outpatients with Common Mental Disorders: The “Choose Change” Effectiveness Trial Psychother. Psychosom. (IF 16.3) Pub Date : 2023-04-06 Andrew T. Gloster, Elisa Haller, Jeanette Villanueva, Victoria Block, Charles Benoy, Andrea H. Meyer, Sandra Brogli, Veronika Kuhweide, Maria Karekla, Klaus Bader, Marc Walter, Undine Lang
Introduction: Treatment non-response occurs regularly, but psychotherapy is seldom examined for such patients. Existing studies targeted single diagnoses, were relatively small, and paid little attention to treatment under real-world conditions. Objective: The Choose Change trial tested whether psychotherapy was effective in treating chronic patients with treatment non-response in a transdiagnostic
-
Effectiveness of Psychotherapy on Prevention of Suicidal Re-Attempts in Psychiatric Emergencies: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Psychother. Psychosom. (IF 16.3) Pub Date : 2023-04-04 Hyunsuk Jeong, Hyeon Woo Yim, Seung-Yup Lee, Marc N. Potenza, Na-Jin Kim
Introduction: Many psychological interventions aim to prevent suicide, but there is limited information regarding their comparative effectiveness. Objectives: We conducted a systematic review and network meta-analysis to evaluate the relative effects of psychological interventions for preventing suicide re-attempts in psychiatric emergencies. Methods: We searched PubMed, Embase, Cochrane, and PsycINFO
-
Cognitive Behavioral Therapy for Late-Life Depression (CBTlate): Results of a Multicenter, Randomized, Observer-Blinded, Controlled Trial Psychother. Psychosom. (IF 16.3) Pub Date : 2023-03-31 Forugh S. Dafsari, Bettina Bewernick, Sabine Böhringer, Katharina Domschke, Moritz Elsaesser, Margrit Löbner, Melanie Luppa, Lukas Preis, Julia Püsken, Sandra Schmitt, Andreea-Johanna Szekely, Martin Hellmich, Wiebke Müller, Michael Wagner, Oliver Peters, Lutz Frölich, Steffi Riedel-Heller, Elisabeth Schramm, Martin Hautzinger, Frank Jessen
Introduction: Different psychotherapeutic interventions for late-life depression (LLD) have been proposed, but their evaluation in large, multicenter trials is rare. Objective: The present study evaluated the efficacy of a specific cognitive behavioral therapy (CBT) for LLD (LLD-CBT) in comparison with a supportive unspecific intervention (SUI), both administered in a specialist psychiatric outpatient
-
Patients as Health Producers: The Psychosomatic Foundation of Lifestyle Medicine Psychother. Psychosom. (IF 16.3) Pub Date : 2023-03-23 Giovanni A. Fava
N/A Psychother Psychosom
-
Evaluating a Comprehensive Model of Euthymia Psychother. Psychosom. (IF 16.3) Pub Date : 2023-03-14
Introduction: In research and treatment of mood disorders, “euthymia” traditionally denotes the absence of clinically significant mood disturbance. A newer, expanded definition of euthymia also includes positive affect and psychological well-being. Objective: We aimed to test this comprehensive model of euthymia and estimate the coherence and predictive power of each factor in the model. Methods: Community-dwelling